Clinical application of neuroendoscopic hematoma removal based on AR technology in the treatment of moderate supratentorial spontaneous intracerebral hemorrhage
XIA Hailong
YANG Gang
ZHENG Chao
Abstract：Objective To investigate the clinical application value of augmented reality(AR)technology-based endoscopic hematoma removal in the treatment of supratentorial spontaneous cerebral hemorrhage.Methods Patients with supratentorial spontaneous cerebral hemorrhage(30-60 ml)admitted to the Department of Neurosurgery at Chongqing Red Cross Hospital(Jiangbei District People's Hospital)from January 2022 to December 2023 were randomly assigned to an AR technology-based endoscopic hematoma removal group(observation group)and a small bone window craniotomy with microscopic hematoma removal group(control group).Surgical parameters,length of hospital stay,incidence of complications,and clinical efficacy were compared between the two groups.Results The observation group showed superior surgical outcomes in terms of operation time,intraoperative blood loss,and hematoma clearance rate compared to the control group,with statistically significant differences(P＜0.05).Additionally,the observation group had a shorter length of hospital stay and a lower incidence of complications than the control group,with statistically significant differences(P＜0.05).The observation group had a significantly better prognosis rate of 87.23%compared to the control group's 66.67%,with statistically significant differences(P＜0.05).Conclusions AR technology-based endoscopic hematoma removal demonstrates advantages over traditional small bone window craniotomy with microscopic hematoma removal in the treatment of supratentorial spontaneous cerebral hemorrhage.
Keywords：Augmented reality technologyNeuroendoscopySupratentorial spontaneous cerebral hemorrhageHematoma removalSmall bone window craniotomy
Publication Date：2025-04-08
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 72-76 )